Cargando…

Meeting report and review: Immunological assays and correlates of protection for next‐generation influenza vaccines

BACKGROUND: This report summarizes the discussions and conclusions from the “Immunological Assays and Correlates of Protection for Next‐Generation Influenza Vaccines” meeting which took place in Siena, Italy, from March 31, 2019, to April 2, 2019. CONCLUSIONS: Furthermore, we review current correlat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krammer, Florian, Weir, Jerry P., Engelhardt, Othmar, Katz, Jacqueline M., Cox, Rebecca Jane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040967/ https://www.ncbi.nlm.nih.gov/pubmed/31837101 http://dx.doi.org/10.1111/irv.12706

Ejemplares similares

Many ways to make an influenza virus – review of influenza virus reverse genetics methods
por: Engelhardt, Othmar G.
Publicado: (2012)

International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISE
por: Laurie, Karen L., et al.
Publicado: (2015)

Developing Vaccines to Combat Pandemic Influenza
por: Robertson, James S., et al.
Publicado: (2010)

Reproducibility of Serologic Assays for Influenza Virus A (H5N1)
por: Stephenson, Iain, et al.
Publicado: (2009)

Development of an ELISA-Based Potency Assay for Inactivated Influenza Vaccines Using Cross-Reactive Nanobodies
por: Cheung, Chung Y., et al.
Publicado: (2022)

A promoter mutation in the haemagglutinin segment of influenza A virus generates an effective candidate live attenuated vaccine
por: Harvey, Ruth, et al.
Publicado: (2014)

Next generation sequencing: new tools in immunology and hematology
por: Mori, Antonio, et al.
Publicado: (2013)

Assay Harmonization and Use of Biological Standards To Improve the Reproducibility of the Hemagglutination Inhibition Assay: a FLUCOP Collaborative Study
por: Waldock, Joanna, et al.
Publicado: (2021)

Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines
por: Dong, Wei, et al.
Publicado: (2018)

An In Vitro Microneutralization Assay for Influenza Virus Serology
por: Cuevas, Frans, et al.
Publicado: (2022)

Validation of a Harmonized Enzyme-Linked-Lectin-Assay (ELLA-NI) Based Neuraminidase Inhibition Assay Standard Operating Procedure (SOP) for Quantification of N1 Influenza Antibodies and the Use of a Calibrator to Improve the Reproducibility of the ELLA-NI With Reverse Genetics Viral and Recombinant Neuraminidase Antigens: A FLUCOP Collaborative Study
por: Bernard, Marie-Clotilde, et al.
Publicado: (2022)

Supporting the Next Generation of Scientists to Lead Cancer Immunology Research
por: Alspach, Elise, et al.
Publicado: (2021)

The consortium for the standardization of influenza seroepidemiology (CONSISE): a global partnership to standardize influenza seroepidemiology and develop influenza investigation protocols to inform public health policy
por: Van Kerkhove, Maria D., et al.
Publicado: (2012)

Cross-Protective Potential and Protection-Relevant Immune Mechanisms of Whole Inactivated Influenza Virus Vaccines Are Determined by Adjuvants and Route of Immunization
por: Bhide, Yoshita, et al.
Publicado: (2019)

Next-Generation Influenza HA Immunogens and Adjuvants in Pursuit of a Broadly Protective Vaccine
por: Nagashima, Kaito A., et al.
Publicado: (2021)

Statistics for Next Generation Sequencing – Meeting Report
por: Wu, Hao, et al.
Publicado: (2012)

Next-generation influenza vaccines: opportunities and challenges
por: Wei, Chih-Jen, et al.
Publicado: (2020)

Next-generation direct-acting influenza therapeutics
por: Toots, Mart, et al.
Publicado: (2020)

Prolonging the delivery of influenza virus vaccine improves the quantity and quality of the induced immune responses in mice
por: Beukema, Martin, et al.
Publicado: (2023)

Meet the Next Generation's Physics Teachers at Physics on Stage
Publicado: (2000)

Biosafety risk assessment for production of candidate vaccine viruses to protect humans from zoonotic highly pathogenic avian influenza viruses
por: Chen, Li‐Mei, et al.
Publicado: (2019)

CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES‐I statement): an extension of the STROBE statement
por: Horby, Peter W., et al.
Publicado: (2016)

Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy
por: Tung Yep, Andrew, et al.
Publicado: (2021)

Generation of a serum free CHO DG44 cell line stably producing a broadly protective anti-influenza virus monoclonal antibody
por: Chromikova, Veronika, et al.
Publicado: (2017)

Next Generation Influenza Vaccines: Looking into the Crystal Ball
por: Guzmán, Carlos Alberto
Publicado: (2020)

Workshop report: Immunoassay standardisation for “universal” influenza vaccines
por: Pavlova, Sophia, et al.
Publicado: (2017)

Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study
por: Waldock, Joanna, et al.
Publicado: (2023)

Next-Generation Human Liver Models for Antimalarial Drug Assays
por: Kulkeaw, Kasem
Publicado: (2021)

Toward Next Generation Lateral Flow Assays: Integration of Nanomaterials
por: Sena-Torralba, Amadeo, et al.
Publicado: (2022)

No evidence of antigenic seniority in hemagglutinin specific antibody responses after adjuvanted pandemic 2009 influenza vaccination
por: Madsen, Anders, et al.
Publicado: (2019)

Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
por: Wohlbold, Teddy John, et al.
Publicado: (2015)

Next-Generation Adjuvants: Applying Engineering Methods to Create and Evaluate Novel Immunological Responses
por: Kim, Jeremiah Y., et al.
Publicado: (2023)

Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity
por: Del Rosario, Joanne Marie M., et al.
Publicado: (2020)

Potency determination of inactivated H7 influenza vaccines using monoclonal antibody‐based ELISA and biolayer interferometry assays
por: Vasudevan, Anupama, et al.
Publicado: (2017)

Next-Generation Computationally Designed Influenza Hemagglutinin Vaccines Protect against H5Nx Virus Infections
por: Nuñez, Ivette A., et al.
Publicado: (2021)

Epidemiological Studies to Support the Development of Next Generation Influenza Vaccines
por: Petrie, Joshua G., et al.
Publicado: (2018)

Author Correction: Next-generation influenza vaccines: opportunities and challenges
por: Wei, Chih-Jen, et al.
Publicado: (2020)

The Next Generation of Influenza Vaccines: Towards a Universal Solution
por: McMillan, Christopher L.D., et al.
Publicado: (2021)

Systems Immunology: Revealing Influenza Immunological Imprint
por: Tomic, Adriana, et al.
Publicado: (2021)

Obesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination
por: Karlsson, Erik A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_21s5me7ege91h6626jov22ad8a